Sequoia Financial Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

Sequoia Financial Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,000	Closed	-$377K	–	401
2019 Q3	$377K	Hold	20,000	–	–	0.03%	237
2019 Q2	$235K	Hold	20,000	–	–	0.02%	321
2019 Q1	$273K	Buy	20,000 +8,500	+74%	+$110K	0.02%	286
2018 Q4	$118K	Hold	11,500	–	–	0.01%	282
2018 Q3	$191K	Hold	11,500	–	–	0.02%	302
2018 Q2	$182K	Hold	11,500	–	–	0.02%	289
2018 Q1	$146K	Hold	11,500	–	–	0.02%	290
2017 Q4	$132K	Sell	11,500 -3,906	-25%	-$43.6K	0.01%	293
2017 Q3	$189K	Buy	+15,406	New	+$161K	0.02%	272

Sequoia Financial Advisors's ALDR Position: Q4 2019 in Review

Sequoia Financial Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 20,000 shares — an estimated $377K sold.

Sequoia Financial Advisors first reported a position in ALDR in Q3 2017 and held it in 9 quarters. The position peaked at $377K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Sequoia Financial Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Sequoia Financial Advisors sold 20,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $377K.
Sequoia Financial Advisors first reported a position in Alder Biopharmaceuticals in Q3 2017 and held it in 9 quarters.
Sequoia Financial Advisors's Alder Biopharmaceuticals position peaked at $377K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Sequoia Financial Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.